FDA advisory committee calls for more data on selinexor for relapsed multiple myeloma - Healio

FDA advisory committee calls for more data on selinexor for relapsed multiple myeloma  Healio

An FDA advisory committee determined the approval of selinexor for treatment of patients with heavily pretreated multiple myeloma should be delayed until ...



Comments

Popular posts from this blog